本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Clovis Oncology

0.0812
0.0000
成交量:- -
成交额:- -
市值:1,177.04万
市盈率:-0.04
高:0.0812
开:0.0812
低:0.0812
收:0.0812
52周最高:3.32
52周最低:0.0760
股本:1.45亿
流通股本:1.43亿
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-1.8161
每股收益(LYR):-2.2897
净资产收益率:193.18%
总资产收益率:-30.18%
市净率:-0.03
市盈率(LYR):-0.04

数据加载中...

2019/12/02

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/15

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/08

员工持股计划

Securities to be offered to employees in employee benefit plans
2019/11/07

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/11/07

重要事件披露

Current report, items 2.02 and 9.01
2019/09/27

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/09/10

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/08/23

重要事件披露

Current report, items 2.03, 3.02, 8.01, and 9.01
2019/08/20

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/08/19

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/08/19

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/08/19

持股变动声明

Statement of changes in beneficial ownership of securities
2019/08/16

持股变动声明

Statement of changes in beneficial ownership of securities
2019/08/16

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/08/15

持股变动声明

Statement of changes in beneficial ownership of securities
2019/08/13

重要事件披露

Current report, items 1.01, 2.03, 3.02, 8.01, and 9.01
2019/08/02

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/08/01

重要事件披露

Current report, items 2.02 and 9.01
2019/07/31

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/10

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals